Estimation of the coefficients of the logistic model used to analyze endpoints assessed for their association with a positive clinical IM response
| Variable . | Coefficient estimate . | SE . | P . |
|---|---|---|---|
| Intercept | 10.8 | 4.82 | < .026* |
| CFC (IM 1μM) | 0.004 | 0.079 | .962 |
| CFC (IM 5μM) | −0.305 | 0.147 | < .039* |
| Variable . | Coefficient estimate . | SE . | P . |
|---|---|---|---|
| Intercept | 10.8 | 4.82 | < .026* |
| CFC (IM 1μM) | 0.004 | 0.079 | .962 |
| CFC (IM 5μM) | −0.305 | 0.147 | < .039* |
CFC refers to the extent of IM inhibition of colony formation by CD34+ CFCs.
The estimated coefficients and P values of the final model show that CFC (IM 5μM) has a significant impact on the IM response at the 5% level.